| OrbiMed Genesis GP LLC |
Delaware |
0 |
148922 |
0 |
10 |
148922 |
0.5 % |
07/11/2022 |
| OrbiMed Genesis GP LLC |
|
0 |
148922 |
0 |
11 |
148922 |
0.5 % |
07/11/2022 |
| OrbiMed Capital LLC |
Cayman Islands |
410683 |
0 |
410683 |
10 |
410683 |
1.5 % |
07/11/2022 |
| OrbiMed Advisors LLC |
|
0 |
1268734 |
0 |
11 |
1268734 |
4.6 % |
07/11/2022 |
| OrbiMed Advisors LLC |
Delaware |
0 |
1268734 |
0 |
10 |
1268734 |
4.6 % |
07/11/2022 |
| OrbiMed Capital LLC |
|
410683 |
0 |
410683 |
11 |
410683 |
1.5 % |
07/11/2022 |
| OrbiMed Capital GP VII LLC |
Delaware |
0 |
1119812 |
0 |
10 |
1119812 |
4.1 % |
07/11/2022 |
| OrbiMed Capital GP VII LLC |
|
0 |
1119812 |
0 |
11 |
1119812 |
4.1 % |
07/11/2022 |
| Arkin Bio Venture Partners Ltd. |
Israel |
0 |
1812315 |
0 |
1812315 |
1812315 |
7.55 % |
12/04/2022 |
| Arkin Bio Ventures Limited Partnership |
Israel |
0 |
1812315 |
0 |
1812315 |
1812315 |
7.55 % |
12/04/2022 |
| Moshe Arkin |
Israel |
0 |
1812315 |
0 |
1812315 |
1812315 |
7.55 % |
12/04/2022 |
| Arkin Bio Venture Partners Ltd. |
Israel |
0 |
1812315 |
0 |
1812315 |
1812315 |
7.55 % |
12/04/2022 |
| Arkin Bio Ventures Limited Partnership |
Israel |
0 |
1812315 |
0 |
1812315 |
1812315 |
7.55 % |
12/04/2022 |
| Moshe Arkin |
Israel |
0 |
1812315 |
0 |
1812315 |
1812315 |
7.55 % |
12/04/2022 |
| Arkin Bio Ventures Limited Partnership |
Israel |
0 |
1812315 |
0 |
1812315 |
1812315 |
7.55 % |
11/04/2022 |
| Arkin Bio Venture Partners Ltd. |
Israel |
0 |
1812315 |
0 |
1812315 |
1812315 |
7.55 % |
11/04/2022 |
| Arkin Bio Ventures Limited Partnership |
Israel |
0 |
1812315 |
0 |
1812315 |
1812315 |
7.55 % |
11/04/2022 |
| Arkin Bio Venture Partners Ltd. |
Israel |
0 |
1812315 |
0 |
1812315 |
1812315 |
7.55 % |
11/04/2022 |
| Moshe Arkin |
Israel |
0 |
1812315 |
0 |
1812315 |
1812315 |
7.55 % |
11/04/2022 |
| Moshe Arkin |
Israel |
0 |
1812315 |
0 |
1812315 |
1812315 |
7.55 % |
11/04/2022 |
| Deep Track Capital, LP |
Delaware |
0 |
1300000 |
0 |
0 |
1300000 |
5.5 % |
14/02/2022 |
| David Kroin |
United States |
0 |
1300000 |
0 |
0 |
1300000 |
5.5 % |
14/02/2022 |
| Deep Track Biotechnology Master Fund, Ltd. |
Cayman Islands |
0 |
1300000 |
0 |
0 |
1300000 |
5.5 % |
14/02/2022 |
| IV”) |
|
0 |
0 |
0 |
0 |
0 |
0 % |
11/02/2022 |
| S James Tananbaum (“Tananbaum”) |
|
0 |
0 |
0 |
0 |
0 |
0 % |
11/02/2022 |
| IV”) |
|
0 |
0 |
0 |
0 |
0 |
0 % |
11/02/2022 |
| (1) BlackRock, Inc. |
Delaware |
1276361 |
0 |
1286526 |
0 |
1286526 |
5.5 % |
03/02/2022 |
| David Kroin |
Delaware |
0 |
1288724 |
0 |
0 |
1288724 |
5.45 % |
30/12/2021 |
| Deep Track Biotechnology Master Fund, Ltd. |
Delaware |
0 |
1288724 |
0 |
0 |
1288724 |
5.45 % |
30/12/2021 |
| Deep Track Biotechnology Master Fund, Ltd. |
Delaware |
0 |
1288724 |
0 |
0 |
1288724 |
5.45 % |
30/12/2021 |
| Deep Track Capital, LP |
Delaware |
0 |
1288724 |
0 |
0 |
1288724 |
5.45 % |
30/12/2021 |
| David Kroin |
Delaware |
0 |
1288724 |
0 |
0 |
1288724 |
5.45 % |
30/12/2021 |
| Deep Track Capital, LP |
Delaware |
0 |
1288724 |
0 |
0 |
1288724 |
5.45 % |
30/12/2021 |
| James Tananbaum (“Tananbaum”) |
|
1412705 |
1412705 |
1412705 |
1412705 |
1412705 |
6.1 % |
16/02/2021 |
| Capital Management IV, LLC (“FCM IV”) |
|
1412705 |
1412705 |
1412705 |
1412705 |
1412705 |
6.1 % |
16/02/2021 |
| Capital Fund IV, L.P. (“FCF IV”) |
|
1412705 |
1412705 |
1412705 |
1412705 |
1412705 |
6.1 % |
16/02/2021 |
| (1)Names of reporting persons. BlackRock, Inc. |
Delaware |
1192897 |
0 |
1199201 |
0 |
1199201 |
5.2 % |
02/02/2021 |
| Arkin Bio Venture Partners Ltd. |
Israel |
0 |
2013102 |
0 |
10 |
2013102 |
8.69 % |
17/12/2020 |
| Alon Lazarus |
Israel |
23038 |
2013102 |
23038 |
10 |
2036140 |
8.79 % |
17/12/2020 |
| Arkin Bio Ventures Limited Partnership |
Israel |
0 |
2013102 |
0 |
10 |
2013102 |
8.69 % |
17/12/2020 |
| Moshe Arkin |
Israel |
0 |
2013102 |
0 |
10 |
2013102 |
8.69 % |
17/12/2020 |
| FMR LLC |
Delaware |
255255 |
0 |
3025881 |
0 |
3025881 |
14.999 % |
10/11/2020 |
| FMR LLC |
Delaware |
255255 |
0 |
3025881 |
0 |
3025881 |
14.999 % |
10/11/2020 |
| Logos Global Master Fund LP |
Delaware |
0 |
1350000 |
0 |
1350000 |
1350000 |
11 % |
31/08/2020 |
| Logos Global Management GP LLC |
Delaware |
0 |
1350000 |
0 |
1350000 |
1350000 |
11 % |
31/08/2020 |
| Logos Global Management LP |
Delaware |
0 |
1350000 |
0 |
1350000 |
1350000 |
11 % |
31/08/2020 |
| Arsani William |
Delaware |
0 |
1350000 |
0 |
1350000 |
1350000 |
11 % |
31/08/2020 |
| Logos Global Management LP |
Delaware |
0 |
1350000 |
0 |
1350000 |
1350000 |
11 % |
31/08/2020 |
| Logos Global Master Fund LP |
Delaware |
0 |
1350000 |
0 |
1350000 |
1350000 |
11 % |
31/08/2020 |
| Logos GP LLC |
Delaware |
0 |
1350000 |
0 |
1350000 |
1350000 |
11 % |
31/08/2020 |
| Arsani William |
Delaware |
0 |
1350000 |
0 |
1350000 |
1350000 |
11 % |
31/08/2020 |
| Logos GP LLC |
Delaware |
0 |
1350000 |
0 |
1350000 |
1350000 |
11 % |
31/08/2020 |
| Logos Global Management GP LLC |
Delaware |
0 |
1350000 |
0 |
1350000 |
1350000 |
11 % |
31/08/2020 |
| Pontifax Late Stage Fund L.P. |
|
0 |
149262 |
0 |
11 |
149262 |
0.7 % |
23/04/2020 |
| Pontifax Management 4 GP Ltd. |
|
0 |
4734507 |
0 |
11 |
4734507 |
23.6 % |
23/04/2020 |
| Pontifax (Israel) IV, L.P. |
|
0 |
2261517 |
0 |
11 |
2261517 |
11.3 % |
23/04/2020 |
| Pontifax (Cayman) IV, L.P. |
|
0 |
1109802 |
0 |
11 |
1109802 |
5.5 % |
23/04/2020 |
| Pontifax (China) IV, L.P. |
|
0 |
1213926 |
0 |
11 |
1213926 |
6 % |
23/04/2020 |
| Pontifax Late Stage Fund L.P. |
|
0 |
149262 |
0 |
11 |
149262 |
0.7 % |
23/04/2020 |
| Pontifax (China) IV, L.P. |
|
0 |
1213926 |
0 |
11 |
1213926 |
6 % |
23/04/2020 |
| Pontifax (Cayman) IV, L.P. |
|
0 |
1109802 |
0 |
11 |
1109802 |
5.5 % |
23/04/2020 |
| Pontifax (Israel) IV, L.P. |
|
0 |
2261517 |
0 |
11 |
2261517 |
11.3 % |
23/04/2020 |
| Pontifax Late Stage GP Ltd. |
|
0 |
149262 |
0 |
11 |
149262 |
0.7 % |
23/04/2020 |
| Pontifax Late Stage GP Ltd. |
|
0 |
149262 |
0 |
11 |
149262 |
0.7 % |
23/04/2020 |
| Pontifax Management 4 GP Ltd. |
|
0 |
4734507 |
0 |
11 |
4734507 |
23.6 % |
23/04/2020 |
| Arkin Bio Ventures Limited Partnership |
Israel |
0 |
2013102 |
0 |
10 |
2013102 |
10.5 % |
20/04/2020 |
| Arkin Bio Ventures Limited Partnership |
|
0 |
2013102 |
0 |
2013102 |
2013102 |
10.5 % |
20/04/2020 |
| Alon Lazarus |
|
23038 |
2013102 |
23038 |
2013102 |
2036140 |
10.6 % |
20/04/2020 |
| Moshe Arkin |
|
0 |
2013102 |
0 |
2013102 |
2013102 |
10.5 % |
20/04/2020 |
| Arkin Bio Venture Partners, Ltd. |
|
0 |
2013102 |
0 |
2013102 |
2013102 |
10.5 % |
20/04/2020 |
| Moshe Arkin |
Israel |
0 |
2013102 |
0 |
10 |
2013102 |
10.5 % |
20/04/2020 |
| Arkin Bio Venture Partners, Ltd. |
Israel |
0 |
2013102 |
0 |
10 |
2013102 |
10.5 % |
20/04/2020 |
| Alon Lazarus |
Israel |
23038 |
2013102 |
23038 |
10 |
2036140 |
10.6 % |
20/04/2020 |
| OrbiMed Advisors LLC |
|
0 |
1268734 |
0 |
11 |
1268734 |
6.3 % |
17/04/2020 |
| OrbiMed Advisors LLC |
Delaware |
0 |
1268734 |
0 |
10 |
1268734 |
6.3 % |
17/04/2020 |
| OrbiMed Capital LLC |
|
410683 |
0 |
410683 |
11 |
410683 |
2 % |
17/04/2020 |
| OrbiMed Genesis GP LLC |
Delaware |
0 |
148922 |
0 |
10 |
148922 |
0.7 % |
17/04/2020 |
| OrbiMed Genesis GP LLC |
|
0 |
148922 |
0 |
11 |
148922 |
0.7 % |
17/04/2020 |
| OrbiMed Capital LLC |
Cayman Islands |
410683 |
0 |
410683 |
10 |
410683 |
2 % |
17/04/2020 |
| OrbiMed Capital GP VII LLC |
Delaware |
0 |
1119812 |
0 |
10 |
1119812 |
5.6 % |
17/04/2020 |
| OrbiMed Capital GP VII LLC |
|
0 |
1119812 |
0 |
11 |
1119812 |
5.6 % |
17/04/2020 |
| Foresite Capital Fund IV, L.P. (“FCF IV”) |
Delaware |
1428071 |
0 |
1428071 |
0 |
1428071 |
7.1 % |
15/04/2020 |
| Foresite Capital Management IV, LLC (“FCM IV”) |
Delaware |
1428071 |
0 |
1428071 |
0 |
1428071 |
7.1 % |
15/04/2020 |
| Foresite Capital Fund IV, L.P. (“FCF IV”) |
Delaware |
1428071 |
0 |
1428071 |
0 |
1428071 |
7.1 % |
15/04/2020 |
| James Tananbaum (“Tananbaum”) |
Delaware |
1428071 |
0 |
1428071 |
0 |
1428071 |
7.1 % |
15/04/2020 |
| James Tananbaum (“Tananbaum”) |
Delaware |
1428071 |
0 |
1428071 |
0 |
1428071 |
7.1 % |
15/04/2020 |
| Foresite Capital Management IV, LLC (“FCM IV”) |
Delaware |
1428071 |
0 |
1428071 |
0 |
1428071 |
7.1 % |
15/04/2020 |